Skip to main content
. 2014 Aug 12;9(8):e104528. doi: 10.1371/journal.pone.0104528

Table 2. Clinical data of healthy subjects and coronary artery disease patients.

Characteristic Healthy controls Coronary artery disease patients p-value
Age, years 33.86±6.32 68.47±14.15 <0.001
Gender (female/male) 11/3 6/13 0.013
BMI 22.42±1.65 25.53±3.37 0.003
TC concentration, mmol/l 4.00±0.57 4.32±0.84 0.222
HDL concentration,mmol/l 1.34±0.95 1.23±0.24 0.082
LDL concentration,mmol/l 2.18±0.53 2.83±1.09 0.031
TG concentration,mmol/l 1.50±0.48 2.11±1.33 0.078
DM 0(10) 4(19) 0.119
Medication
Platelet inhibitor 0(10) 10(19) -
Beta-blocker 0(10) 3(19) -
ACE-I/ARB 0(10) 2(19) -
Calcium channel blockers 0(10) 5(19) -

Values are expressed as the mean ±SD or as the number of subjects. BMI: body mass index; DM: diabetes mellitus; TC: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglyceride; ACE-I/ARB: angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker. A value of P<0.05 was considered significant difference.